VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 125 filers reported holding VERVE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $267,295 | -29.6% | 20,158 | -0.5% | 0.00% | – |
| Q2 2023 | $379,857 | +19.3% | 20,259 | -8.3% | 0.00% | – |
| Q1 2023 | $318,408 | +1.2% | 22,081 | +35.8% | 0.00% | – |
| Q4 2022 | $314,593 | -94.5% | 16,258 | -90.2% | 0.00% | -100.0% |
| Q3 2022 | $5,674,000 | +2722.9% | 165,176 | +1159.1% | 0.00% | – |
| Q2 2022 | $201,000 | -11.1% | 13,119 | +32.5% | 0.00% | – |
| Q1 2022 | $226,000 | -16.0% | 9,899 | +35.7% | 0.00% | – |
| Q4 2021 | $269,000 | +8.5% | 7,293 | +38.4% | 0.00% | – |
| Q3 2021 | $248,000 | – | 5,269 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |